CorTec
Enabled computer control and stimulation in one implant
Neuralink
Reported speech at 75 words per minute in an ALS trial
Paradromics
Enabled real-time speech with its implanted Connexus BCI
Precision Neuroscience
Built a neural atlas from recordings across 70 patients
Science
Secured European CE marking for its PRIMA retinal implant
Flow Neuroscience
Launched its at-home depression headset in the US market
Neurolief
Expanded VA access to depression and migraine therapies
Neurovalens
Won FDA authorization for its home-use PTSD therapy
Salvia BioElectronics
Implanted its first US patient in a pivotal migraine trial
Wave Neuroscience
Won FDA clearance for MeRT as adjunct PTSD treatment
Ceribell
Won FDA clearance for new bedside EEG trending software
Oculogica
Won FDA clearance for its SNAP concussion assessment
Universal Brain
Won FDA clearance for its EEG-based UB ERP platform
UNEEG
Secured FDA clearance for its EpiSight EEG monitoring system
Hyperfine
Won FDA clearance for its latest Optive AI MRI software
Cerca Magnetics
Raised £3.8m to scale its wearable brain imaging systems
Omniscient
Raised $27.2m to expand its Quicktome brain-mapping platform
Subtle Medical
Won FDA clearances for AI-enhanced PET and CT imaging
EMVision
Expanded its pivotal trial for portable stroke scanning
Atlas
Opened preorders for its behind-the-ear EEG brain wearable
Connectome Health
Opened its London brain-performance clinic to the public
Neurable
Launched Neurable One headphones with integrated EEG
NextSense
Began shipping EEG earbuds with responsive sleep audio
Pulsetto
Launched FIT X, its latest consumer nerve-stimulation device
Cortical Labs
Deployed a 20-unit biological computing system at NUS
CraniUS
Secured FDA clearances for two cranial plate configurations
MintNeuro
Partnered with Motif to develop chips for neural implants
OpenBCI
Launched the Galea Discovery Program for research teams
The Biological Computing Co.
Released a commercial AI video model derived from neurons
Epia Neuro
Emerged from stealth with a BCI targeting stroke recovery
Merge Labs
Launched with $252m to develop new brain-computer interfaces
Gestala
Raised $84m in six months to develop ultrasound BCIs
Aleph Neuro
Partnered with Butterfly to develop ultrasound BCIs
ReEmerge
Emerged with $37m to develop DBS for brain injury recovery
Neuracle
Won Chinese market approval for its hand-control BCI system
Neuralink
Reported speech at 75 words per minute in an ALS trial
Science
Secured European CE marking for its PRIMA retinal implant
Neurovalens
Won FDA authorization for its home-use PTSD therapy
CorTec
Enabled computer control and stimulation in one implant
Chosen by the jury from the six category winners.


Any neurotechnology company with a public milestone in 2026 in one of the six sectors: a funding round, a regulatory decision, a clinical result, a product launch or a partnership.
Neurofounders shortlisted five companies per category from its 2026 coverage and the startup map, based on how significant each company’s progress was during the year.
Each category winner is decided by combining two rankings: the jury counts for 60% and the public vote for 40%. Neurotech company of the year is chosen by the jury from the six category winners.
Jury members do not score a category in which they have a financial, advisory or employment link with a finalist. Sponsors and partners have no say in the shortlist or the results.
One vote per email address. Votes are checked for duplicates and automated submissions before counting, and invalid votes are removed.
Know a company that should be on next year’s shortlist? Send it to us.